CD68+HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway

Cancer Letters

Volumn 345, Issue 1, 2014, Pages 91-99

  Wang, Hao ^a   Wang, Xianteng ^a   Li, Xia ^b   Fan, Yuchen ^c   Li, Guosheng ^c   Guo, Chun ^a   Zhu, Faliang ^a   Zhang, Lining ^a   Shi, Yongyu ^a  

^a SHANDONG UNIVERSITY   (China)

^b No 6 People's Hospital of Jinan   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

FAK; Hepatocellular carcinoma; NF B; Tumor associated macrophage

Indexed keywords

FAK; HEPATOCELLULAR CARCINOMA; NF-ΚB; TUMOR-ASSOCIATED MACROPHAGE;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; FOCAL ADHESION KINASE 1; HEP G2 CELLS; HLA-DR ANTIGENS; HUMANS; LIVER NEOPLASMS; MACROPHAGES; NEOPLASM METASTASIS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84893816088     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.11.013     Document Type: Article

References (38)

1. Tang Z.Y. Hepatocellular carcinoma surgery-review of the past and prospects for the 21st century. J. Surg. Oncol. 2005, 91(2):95-96.
2. Jia J.B., Wang W.Q., Sun H.C., Zhu X.D., Liu L., Zhuang P.Y., Zhang J.B., Zhang W., Xu H.X., Kong L.Q., Lu L., Wu W.Z., Wang L., Tang Z.Y. High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection. Oncologist 2010, 15(7):732-743.
3. Ju M.J., Qiu S.J., Fan J., Xiao Y.S., Gao Q., Zhou J., Li Y.W., Tang Z.Y. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am. J. Clin. Pathol. 2009, 131(4):498-510.
4. Ding T., Xu J., Wang F., Shi M., Zhang Y., Li S.P., Zheng L. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum. Pathol. 2009, 40(3):381-389.
5. Zhang W., Zhu X.D., Sun H.C., Xiong Y.Q., Zhuang P.Y., Xu H.X., Kong L.Q., Wang L., Wu W.Z., Tang Z.Y. Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin. Cancer Res. 2010, 16(13):3420-3430.
6. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012, 12(4):253-268.
7. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23(11):549-555.
8. Galdiero M.R., Garlanda C., Jaillon S., Marone G., Mantovani A. Tumor associated macrophages and neutrophils in tumor progression. J. Cell Physiol. 2013, 228(7):1404-1412.
9. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122(3):787-795.
10. Mantovani A., Germano G., Marchesi F., Locatelli M., Biswas S.K. Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur. J. Immunol. 2011, 41(9):2522-2525.
11. Wu Y., Zheng L. Dynamic education of macrophages in different areas of human tumors. Cancer Microenviron. 2012, 5(3):195-201.
12. Biswas S.K., Sica A., Lewis C.E. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 2008, 180(4):2011-2017.
13. Movahedi K., Laoui D., Gysemans C., Baeten M., Stangé G., Van den Bossche J., Mack M., Pipeleers D., In't Veld P., De Baetselier P., Van Ginderachter J.A. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010, 70(14):5728-5739.
14. Van Ginderachter J.A., Movahedi K., Hassanzadeh Ghassabeh G., Meerschaut S., Beschin A., Raes G., De Baetselier P. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 2006, 211(6-8):487-501.
15. Kuang D.M., Zhao Q., Peng C., Xu J., Zhang J.P., Wu C., Zheng L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 2009, 206(6):1327-1337.
16. Ma J., Liu L., Che G., Yu N., Dai F., You Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 2010, 10:112.
17. Wada N., Zaki M.A., Hori Y., Hashimoto K., Tsukaguchi M., Tatsumi Y., Ishikawa J., Tominaga N., Sakoda H., Take H., Tsudo M., Kuwayama M., Morii E., Aozasa K. Osaka lymphoma study group. Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka lymphoma study group. Histopathology 2012, 60(2):313-319.
18. Hasan D., Chalouhi N., Jabbour P., Hashimoto T. Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results. J. Neuroinflamm. 2012, 9:222.
19. Ino Y., Yamazaki-Itoh R., Shimada K., Iwasaki M., Kosuge T., Kanai Y., Hiraoka N. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br. J. Cancer 2013, 108(4):914-923.
20. Tjiu J.W., Chen J.S., Shun C.T., Lin S.J., Liao Y.H., Chu C.Y., Tsai T.F., Chiu H.C., Dai Y.S., Inoue H., Yang P.C., Kuo M.L., Jee S.H. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J. Invest. Dermatol. 2009, 129(4):1016-1025.
21. Ohri C.M., Shikotra A., Green R.H., Waller D.A., Bradding P. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur. Respir. J. 2009, 33(1):118-126.
22. Zaki M.A., Wada N., Ikeda J., Shibayama H., Hashimoto K., Yamagami T., Tatsumi Y., Tsukaguchi M., Take H., Tsudo M., Morii E., Aozasa K. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch. 2011, 459(4):361-366.
23. Laoui D., Movahedi K., Van Overmeire E., Van den Bossche J., Schouppe E., Mommer C., Nikolaou A., Morias Y., De Baetselier P., Van Ginderachter J.A. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int. J. Dev. Biol. 2011, 55(7-9):861-867.
24. Budhu A., Forgues M., Ye Q.H., Jia H.L., He P., Zanetti K.A., Kammula U.S., Chen Y., Qin L.X., Tang Z.Y., Wang X.W. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006, 10(2):99-111.
25. Mano Y., Aishima S., Fujita N., Tanaka Y., Kubo Y., Motomura T., Taketomi A., Shirabe K., Maehara Y., Oda Y. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma. Pathobiology 2013, 80(3):146-154.
26. Ueno Y., Sakurai H., Matsuo M., Choo M.K., Koizumi K., Saiki I. Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. Br. J. Cancer 2005, 92(9):1690-1695.
27. Sheikh S.Z., Plevy S.E. The role of the macrophage in sentinel responses in intestinal immunity. Curr. Opin. Gastroenterol. 2010, 26(6):578-582.
28. Li Y., Wu J., Zhang W., Zhang N., Guo H. Identification of serum CCL15 in hepatocellular carcinoma. Br. J. Cancer 2013, 108(1):99-106.
29. Li J., Lau G., Chen L., Yuan Y.F., Huang J., Luk J.M., Xie D., Guan X.Y. Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression. PLoS One 2012, 7(9):e46264.
30. Schaller M.D. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J. Cell. Sci. 2010, 123(Pt 7):1007-1013.
31. Liu Z., Zhang H.M., Yuan J., Lim T., Sall A., Taylor G.A., Yang D. Focal adhesion kinase mediates the interferon-gamma-inducible GTPase-induced phosphatidylinositol 3-kinase/Akt survival pathway and further initiates a positive feedback loop of NF-kappaB activation. Cell Microbiol. 2008, 10(9):1787-1800.
32. Heusinkveld M., van der Burg S.H. Identification and manipulation of tumor associated macrophages in human cancers. J. Transl. Med. 2011, 9:216.
33. Schwende H., Fitzke E., Ambs P., Dieter P. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukoc. Biol. 1996, 59(4):555-561.
34. Sica A., Allavena P., Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 2008, 267(2):204-215.
35. Mantovani A., Pierotti M.A. Cancer and inflammation: a complex relationship. Cancer Lett. 2008, 267(2):180-181.
36. Wu J.M., Sheng H., Saxena R., Skill N.J., Bhat-Nakshatri P., Yu M., Nakshatri H., Maluccio M.A. NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy. Cancer Lett. 2009, 278(2):145-155.
37. Rakhmilevich A.L., Alderson K.L., Sondel P.M. T-cell-independent antitumor effects of CD40 ligation. Int. Rev. Immunol. 2012, 31(4):267-278.
38. Kramer N., Walzl A., Unger C., Rosner M., Krupitza G., Hengstschläger M., Dolznig H. In vitro cell migration and invasion assays. Mutat. Res. 2013, 752(1):10-24.